Consistent with the findings from the Phase II trial in asthma and our previous publication in the context of viral bronchiolitis11,19, we observed that DP2 antagonism or DP1 agonism reversed established ASM area, mucus hypersecretion, and collagen deposition. Here, PTGDR is linked to asthma.